Kisspeptin-54 Stimulates Gonadotropin Release Most Potently during the Preovulatory Phase of the Menstrual Cycle in Women
Open Access
- 1 October 2007
- journal article
- clinical trial
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 92 (10), 3958-3966
- https://doi.org/10.1210/jc.2007-1116
Abstract
Context: Kisspeptin, the endogenous ligand of the G protein-coupled receptor 54, is a key regulator of the hypothalamo-pituitary-gonadal (HPG) axis. GPR54-null mice exhibit reproductive dysfunction, and exogenous kisspeptin potently stimulates the HPG axis in rodents, primates, and human males. The effects of kisspeptin administration to human females are unknown. Objective: Our objective was to investigate the effects of kisspeptin on LH release during the menstrual cycle in female volunteers. Design: Bolus sc kisspeptin-54 was administered to female volunteers, and plasma gonadotropins were measured. Setting: The study took place at a hospital clinical research facility. Volunteers: Subjects were healthy female volunteers with regular menstrual cycles. Intervention: 1) Volunteers received a sc bolus injection of kisspeptin-54 (0, 0.2, 0.4, 0.8, 1.6, 3.2, and 6.4 nmol/kg; n = 3–4 per dose) in the follicular phase; and 2) volunteers (n = 8) received a sc bolus injection of either kisspeptin-54 (0.4 nmol/kg) or saline in random order during each phase of the menstrual cycle. Main Outcome Measures: Plasma gonadotropins were measured. Results: 1) Kisspeptin-54 caused a dose-dependent increase in mean LH over time at doses from 0.2–6.4 nmol/kg. 2) Kisspeptin-54 increased plasma LH compared with saline injection in all phases of the cycle. The effect of kisspeptin was greatest in the preovulatory phase and least in the follicular phase of the cycle [mean increase in LH over baseline (IU/liter) ± sem for follicular phase was 0.12 ± 0.17; preovulatory phase, 20.64 ± 2.91 (P < 0.001 vs. follicular phase); luteal phase, 2.17 ± 0.79 (P < 0.01 vs. follicular phase)]. Conclusion: Elevation of plasma kisspeptin in human females potently stimulates LH release in the preovulatory phase and provides a novel mechanism for manipulation of the HPG axis in women.Keywords
This publication has 50 references indexed in Scilit:
- Effects of KiSS-1 Peptide, the Natural Ligand of GPR54, on Follicle-Stimulating Hormone Secretion in the RatEndocrinology, 2005
- Characterization of the Potent Luteinizing Hormone-Releasing Activity of KiSS-1 Peptide, the Natural Ligand of GPR54Endocrinology, 2005
- Central and Peripheral Administration of Kisspeptin‐10 Stimulates the Hypothalamic‐Pituitary‐Gonadal AxisJournal of Neuroendocrinology, 2004
- Developmental and Hormonally Regulated Messenger Ribonucleic Acid Expression of KiSS-1 and Its Putative Receptor, GPR54, in Rat Hypothalamus and Potent Luteinizing Hormone-Releasing Activity of KiSS-1 PeptideEndocrinology, 2004
- Peripheral administration of metastin induces marked gonadotropin release and ovulation in the ratBiochemical and Biophysical Research Communications, 2004
- Kisspeptin Activation of Gonadotropin Releasing Hormone Neurons and Regulation of KiSS-1 mRNA in the Male RatNeuroendocrinology, 2004
- The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive systemBiochemical and Biophysical Research Communications, 2003
- TheGPR54Gene as a Regulator of PubertyThe New England Journal of Medicine, 2003
- Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54Proceedings of the National Academy of Sciences of the United States of America, 2003
- The Metastasis Suppressor Gene KiSS-1 Encodes Kisspeptins, the Natural Ligands of the Orphan G Protein-coupled Receptor GPR54Journal of Biological Chemistry, 2001